SABCS Snippets: Results of the WISDOM 1.0 Trial

From SABCS 2025: Symposium Co-director Virginia Kaklamani, MD, talks with Laura Esserman, MD, about the results of the WISDOM 1.0 study, which demonstrated that a risk-based approach to breast cancer screening is safe and acceptable to women and can improve breast cancer early detection and prevention by identifying the highest risk women who should be screened more frequently and offering risk reduction options while reducing screening burden for average risk women.